Albertsons Companies (ACI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for August 8, 2024, to be held virtually, with voting on director elections, auditor ratification, and executive compensation advisory vote.
Continued focus on the proposed merger with Kroger, aiming to expand reach, lower prices, and enhance customer and associate experience.
Fiscal 2023 saw $79.2 billion in sales, $1.3 billion net income, and $1.7 billion adjusted net income; $276 million returned to shareholders via dividends.
Strategic priorities included digital engagement, store experience, product innovation, operational modernization, and community impact.
Voting matters and shareholder proposals
Proposals include electing 11 directors, ratifying Deloitte and Touche LLP as auditor, and an advisory vote on executive compensation.
Board recommends voting “FOR” all proposals.
Shareholders of record as of June 11, 2024, are eligible to vote.
Procedures for submitting proposals and director nominations for the 2025 meeting are outlined.
Board of directors and corporate governance
Board consists of 11 members, majority independent, with two new directors appointed in 2023 to enhance diversity.
All standing committees are fully independent; separation of CEO and Chair roles; annual board and committee evaluations.
Cerberus, the largest stockholder, retains rights to nominate up to four directors based on ownership.
Board skills include financial literacy, risk management, food and retail, technology, and strategic planning.
Latest events from Albertsons Companies
- Q3 delivered solid sales and digital growth, but faces post-merger litigation and margin pressure.ACI
Q3 202410 Jan 2026 - Identical sales and digital growth lifted revenue, but margins narrowed amid ongoing investments.ACI
Q1 20259 Jan 2026 - Q3 2025 saw 2.4% identical sales growth, strong digital gains, and major capital actions.ACI
Q3 20257 Jan 2026 - Q2 2025 saw 2.0% revenue growth, higher net income, and a $750M share buyback announcement.ACI
Q2 20257 Jan 2026 - Q4 delivered strong digital and pharmacy growth, but margin pressure tempers 2025 optimism.ACI
Q4 202419 Dec 2025 - Board recommends against all shareholder proposals; focus remains on digital growth and ESG impact.ACI
Proxy Filing1 Dec 2025 - Annual proxy statement outlines voting items and confirms standard shareholder meeting.ACI
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting, with no fee required.ACI
Proxy Filing1 Dec 2025 - All directors attended at least 75% of board and committee meetings in fiscal 2024.ACI
Proxy Filing1 Dec 2025